Système cardiovasculaire - MedQual

56. Pfisterer M, Buser P, Osswald S et al. Outcome of elderly patients with chronic symptomatic coronary
artery disease with an invasive vs optimized medical treatment strategy. JAMA 2003;289:1117-1123.
57. Al-Mallah M, Tleyjeh I, Abdel-Latif A et al. Angiotensin-converting enzyme inhibitors in coronary artery
disease and preserved left ventricular systolic function. JACC 2006;47:1576-1583.
58. Danchin N, Cucherat M, Thuillez M et al. Angiotensin-converting enzyme inhibitors in patients with
coronary artery disease and absence of heart failure or left ventricular systolic dysfunction. Arch Intern
Med 2006;166:787-796.
59. Gueyffier F, Bulpitt C, Boissel JP et al. Antihypertensive drugs in very old people: a subgroup metaanalysis
of randomised controlled trials. INDANA Group. Lancet 1999;353:793-6.
60. Oates D et al. Blood pressure and survival in the oldest old. J Am Geriatr Soc 2007;55:383-388.
61. Fagard R. Do we need drug therapy to manage mild hypertension in the elderly Drugs Aging
2004;21:1-6.
62. Klungel O, Grobbee D, de Boer A. Het onderbouwd voorschrijven van antihypertensiva bij hypertensie.
Geneesmiddelenbulletin 2005;39:13-24.
63. Staessen J, Fagard R, Thijs L et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Lancet 1997;350:757-64.
64. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older
persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly
Program (SHEP). JAMA 1991;265:3255-64.
65. Staessen J, Gasowski J, Wang J et al. Risks of untreated and treated isolated systolic hyperension in the
elderly: meta-analysis of outcome trials. Lancet 2000:355:865-72.
66. Chaudry S et al. Systolic hypertension in older persons. JAMA 2004;292:1074-1080.
67. He F, MacGregor G. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database
of Systematic Reviews 2004, Issue 1. Art. No.: CD004937. DOI: 10.1002/14651858.CD004937.
68. Sheridan S. Primary prevention: hypertension. BMJ Clin Evid [online] 2007 [cited dec 2007].
www.clinicalevidence.com
69. Psaty B, Weiss N, Furberg C. Recent trials in hypertension. Compelling science or commercial speech
JAMA 2006;295:1704-1706.
70. NICE. Management of hypertension in primary care: partial update. June 2006. www.nice.org.uk
71. Dahlof B, Sever P, Poulter N et al. Prevention of cardiovascular events with an antihypertensive regimen
of amlodipine adding perindopril as required vs atenolol adding bendroflumethiazide as required in the
Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre
randomised controlled trial. Lancet 2005;366:895-906.
72. Staessen J, Birkenhäger W. Evidence that new antihypertensives are superior to older drugs. Lancet
2005;366:869-871.
73. Anonymous. L’étude ASCOT sur le traitement antihypertenseur. Folia Pharmacotherapeutica
2005;32:86-87. www.cbip.be
74. Bijl D, Kerst A. Het ASCOT-onderzoek: vergelijking van twee antihypertensieve combinaties, vertrouwd
versus modern. Geneesmiddelenbulletin 2006;40:12-14.
75. ASCOT-trial: nieuwe hypertensiva of toch gewoon classics Huisarts Wet 2005;48:589.
76. Zur Ascot-Studie: neuere Antihypertensiva wirklich besser Arznei-Telegramm 2005;36:85-86.
77. Anonymous. HTA: L’essai ASCOT-BPLA ne change pas la stratégie thérapeutique. La Revue Prescrire
2006;26:205-206.
78. Christiaens T, De Sutter J. Hypertensiebehandeling in de eerste lijn: consensus en evidentie. Tijdschr voor
Geneeskunde 2001;57:1617-24.
79. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major Outcomes
in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium
Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
Trial (ALLHAT). JAMA 2002;288:2981-2997.
80. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the
antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT
Collaborative Research Group. JAMA 2000;283:1967-1975.
81. Psaty B et al. Health outcomes associated with various antihypertensive therapies used as first-line
agents: a network meta-analysis. JAMA 2003;289:2534-2544.
82. Vijan S. Hypertension in diabetes. BMJ Clin Evid [online] 2006 [cited dec 2006].
www.clinicalevidence.com
83. Kostis J, Wilson A, Freudenberger R et al. Long-term effect of diuretic-based theraopy on fatal outcomes
in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35.
Système cardiovasculaire 35